Mechanisms of Loxo-305 in Treating Rheumatoid Arthritis by Dual Inhibition of B Cell Activity and Osteoclast Differentiation

Xuena Wang, Lianjie Cheng, Aihua Liu

PDF(23553 KB)
For Authors|For Editors|For Reviewers
PDF(23553 KB)
Discovery Medicine ›› 2025, Vol. 37 ›› Issue (198) : 1385-1398. DOI: 10.24976/Discov.Med.202537198.120
Article

Mechanisms of Loxo-305 in Treating Rheumatoid Arthritis by Dual Inhibition of B Cell Activity and Osteoclast Differentiation

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

Highlight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2025, 37(198): 1385-1398 https://doi.org/10.24976/Discov.Med.202537198.120

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(23553 KB)

Accesses

Citation

Detail
Sections
Recommended
Follow Us on
Copyright © 2025.
By using this website, you agree to our Terms & Conditions and Privacy Policy.  
  • Disclaimer
    The statements, opinions and data contained in Discovery Medicine are solely those of the individual authors and contributors and not of the journal and the editor(s). Discovery Medicine stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

    • /

    〈 〉